You are currently viewing a new version of our website. To view the old version click .

Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Letter

1 April 2016

Response to: Second-Line Treatment of Non-Small-Cell Lung Cancer with Wild-Type EGFR Status. What Is the Best Approach?

,

,

and

¹

Division of Hematology/Oncology, McGill University, Montreal, QC, Canada

²

Peter Brojde Lung Cancer Centre, Jewish General Hospital, Montreal, QC, Canada

^*

Author to whom correspondence should be addressed.

Curr. Oncol.2016, 23(2), 160-161;https://doi.org/10.3747/co.23.2955

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

We thank Drs. Ibrahim Elghissassi, Saber Boutayeb, Hanane Inrhaoun, Hind Mrabti, and Hassan Errihani for their comments on our paper [...]

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

Second-Line Treatment of Non-Small-Cell Lung Cancer with Wild-Type EGFR Status. What Is the Best Approach?

Accrual of Adolescents and Young Adults with Cancer to Clinical Trials